Baskhanbio Pharma Inc. (XKON:354390)
South Korea · Delayed Price · Currency is KRW 4,945.00
-50.00 (-1.00%)
At close: May 11, 2026
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 34.71 billion as of May 11, 2026. Its market cap has increased by 7.50% in one year.
Market Cap
34.71B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,945.00
Market Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 34.71B, a decrease of -58.09%. That is a compound annual growth rate of -20.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 35.06B | 4.50% |
| Dec 30, 2025 | 33.55B | 11.42% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
| Jul 20, 2022 | 82.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eagle Veterinary Technology Co.,Ltd | 48.61B |
| Kyung Nam Pharm | 47.28B |
| Korean Drug | 42.07B |
| HLscience | 41.30B |
| GeneBioTech Co. ,Ltd | 35.65B |
| Seoul Pharma | 30.31B |
| Pharmsville | 27.51B |
| ChoA Pharmaceutical Co., LTD. | 27.42B |